BRACKEN

Radiopharma Roundtable

Expert Perspectives on the Future of Radiopharmaceuticals

Bracken’s Radiopharma Roundtable is an ongoing conversation series featuring expert perspectives on the evolving radiopharmaceutical landscape.

Each roundtable brings together experienced peers from across the field to discuss the strategic, operational, clinical, and commercial considerations shaping radiopharmaceutical development today. From trial complexity and site readiness to patient identification, program planning, and market evolution, these conversations are designed to surface practical insights from those actively engaged in the space.

Radiopharma Roundtable Recordings

When Trials Get Too Complex – Does Radiopharmaceutical Development Have a Short Half-Life

SESSION 1

When Trials Get Too Complex — Do Radiopharmaceutical Programs Have a Short Half-Life?

with BEN LARIMER, PHD; Colin MilleR, PHD, FIPEM, CSCI; SANDY MCEWAN, MB, MSc, FRCPC; Ovid Trifan, MD, PhD

Through a moderated roundtable conversation, the panel shared practical perspectives, real-world considerations, and peer-driven insights on the path forward for radiopharmaceutical programs.

Register for future sessions.

LEARN MORE